OPDP Researchers Plan Survey on How Consumers Interpret Specific Quantitative Claims

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

OPDP Researchers Plan Survey on How Consumers Interpret Specific Quantitative Claims

J.W. Schomisch

April 25, 2023 at 02:32 PM EST

FDA Office of Prescription Drug Promotion (OPDP) researchers plan to conduct a survey on quantitative claims in direct-to-consumer (DTC) prescription drug advertising. According to a Federal Register notice (88 Fed. Reg. 24997) the researchers will use an address-based, mixed-mode methodology that will direct one randomly chosen member of sampled households to complete a 20-m... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

OPDP Researchers Plan Survey on How Consumers Interpret Specific Quantitative Claims

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT